Silgan Unicep — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Silgan Unicep is a specialized contract development and manufacturing organization (CDMO) focused on unit-dose liquid and semi-solid drug delivery systems. As a subsidiary of Silgan Dispensing, it leverages over 30 years of expertise in blow-fill-seal (BFS) and other proprietary packaging technologies to serve pharmaceutical, diagnostic, and consumer health clients. The company's core value proposition lies in its integrated services—from R&D and formulation to compliant manufacturing and packaging—catering to complex, low-volume, high-value products. Its business model is entirely service-based, generating revenue through contract manufacturing fees.

Drug DeliveryMedical Devices

Technology Platform

Specialized in unit-dose drug delivery systems, primarily leveraging Blow-Fill-Seal (BFS) technology and proprietary packaging formats (HLX PreciseDose™, MicroDose, Twist-Tip™) for liquids, gels, and creams. Offers integrated services from formulation R&D to aseptic filling and secondary packaging.

Opportunities

Growth is driven by trends in precision dosing, expansion of point-of-care diagnostics, and the booming animal health market, all requiring specialized unit-dose packaging.

The continued outsourcing by pharma and biotech companies to reduce capex and access expertise provides a steady stream of potential clients.

Risk Factors

Revenue is project-based and can be volatile.

The company faces significant regulatory compliance risk in its FDA/ISO-regulated operations.

It operates in a competitive CDMO landscape and is exposed to supply chain and input cost inflation for materials like polymers.

Competitive Landscape

Competes with other specialized CDMOs focusing on complex liquid and semi-solid dose forms, as well as larger, diversified CDMOs that offer unit-dose filling as part of broader services. Differentiation is achieved through deep expertise in proprietary BFS-based packaging formats and a partnership-oriented service model for niche, high-value products.

More companies in Drug Delivery & Formulation →More companies in United States →